Trendlines Medical Shanghai opens its doors

Editors note: News of the establishment of Trendlines Medical Shanghai appeared in LaingBuison and in Yahoo Finance. 

Trendlines Medical Shanghai leverages Trendlines’ innovation strengths and experience in the medical device industry and its unique incubation model in Israel and Singapore. Combining Israel’s technological and innovation capabilities, together with Chinese medical companies’ targeted R&D projects, and partnerships with government funds, Trendlines Medical Shanghai will incubate and commercialize new companies to answer China’s and global healthcare needs. Trendlines Medical Shanghai will bring outstanding medical device portfolio companies established by Trendlines in Israel and Singapore to the Chinese market.

Trendlines Medical Shanghai is located in the China-Israel Innovation Hub in Shanghai’s Putuo District (“CIIH”). CIIH focuses on innovation through joint ventures. CIIH is positioning itself as a platform for R&D, technology exchange, and business incubation, focused on needs from local medical device companies.

Commenting on the establishment of Trendlines Medical Shanghai, Todd Dollinger, Chairman and CEO of The Trendlines Group,

“We believe that our strengths and experience in bringing medical device technologies from idea to commercialization, together with China’s strong engineering and production capacity, combined with enormous market demand, creates fertile ground for the success of Trendlines Medical Shanghai. We look forward to growing our China operations in Shanghai and bringing together Israeli, Singaporean, and Chinese talent to fulfill our mission of improving the human condition”


Trendlines Medical Shanghai CEO Tony Lou remarked,

“An international financial center, Shanghai has an abundance of resources, including world-class medical facilities and prestigious universities and R&D institutions that provide a strong foundation for the development of innovative medical devices. Joining forces with Trendlines utilizes the respective advantages of China and Israel to bring new medical products to market.”